Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585364 · ClinicalTrials.gov registry record
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 79
- Enrollment target
NCT00585364 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 79 participants.
The verdict
NCT00585364 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The goal of this study is to identify the immunological factors that influence a patient's response to the presence of the fungus Aspergillus fumigatus (A. fumigatus) in the lungs. In patients with cystic fibrosis (CF), this fungus is not known to cause damage to the lungs, but some patients respond with an allergic reaction that may cause wheeze, cough, or difficulty breathing. Approximately 230 patients will be enrolled with an additional 60 people who do not have CF and who do not have a history of asthma to serve as a comparison group.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585364
The ClinicalTrials.gov registry entry for NCT00585364 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00585364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585364 about?
NCT00585364 is a clinical study titled "Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA". The goal of this study is to identify the immunological factors that influence a patient's response to the presence of the fungus Aspergillus fumigatus (A. fumigatus) in the lungs. In patients with cystic fibrosis (CF), this fungus is not known to cause damage to the lungs, but some patients respond...
What is the current status of trial NCT00585364?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2005-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00585364?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.